AU2003212246A1 - Method for diagnosis of inflammatory diseases using mrp8/mrp14 - Google Patents
Method for diagnosis of inflammatory diseases using mrp8/mrp14Info
- Publication number
- AU2003212246A1 AU2003212246A1 AU2003212246A AU2003212246A AU2003212246A1 AU 2003212246 A1 AU2003212246 A1 AU 2003212246A1 AU 2003212246 A AU2003212246 A AU 2003212246A AU 2003212246 A AU2003212246 A AU 2003212246A AU 2003212246 A1 AU2003212246 A1 AU 2003212246A1
- Authority
- AU
- Australia
- Prior art keywords
- mrp14
- mrp8
- diagnosis
- inflammatory diseases
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7748602A | 2002-02-15 | 2002-02-15 | |
US10/077,486 | 2002-02-15 | ||
PCT/EP2003/001576 WO2003069349A2 (en) | 2002-02-15 | 2003-02-17 | Method for diagnosis of inflammatory diseases using mrp8/mrp14 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003212246A1 true AU2003212246A1 (en) | 2003-09-04 |
AU2003212246A8 AU2003212246A8 (en) | 2003-09-04 |
Family
ID=27732668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003212246A Abandoned AU2003212246A1 (en) | 2002-02-15 | 2003-02-17 | Method for diagnosis of inflammatory diseases using mrp8/mrp14 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003212246A1 (en) |
WO (1) | WO2003069349A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070123455A1 (en) * | 2003-04-04 | 2007-05-31 | Joel Palefsky | Immunomodulatory agents for treatment of inflammatory diseases |
FR2841786A1 (en) * | 2003-06-13 | 2004-01-09 | Biomerieux Stelhys | Use of specific polypeptides of the calgranulin B family for diagnosis and therapy of degenerative, neurological or autoimmune diseases, especially multiple sclerosis |
SG150497A1 (en) | 2004-07-23 | 2009-03-30 | Aspenbio Pharma Inc | Methods and devices for diagnosis of appendicitis |
US7659087B2 (en) | 2004-07-23 | 2010-02-09 | Aspenbio Pharma, Inc. | Methods and devices for diagnosis of appendicitis |
WO2006122723A1 (en) * | 2005-05-19 | 2006-11-23 | Vaecgene Biotech Gmbh | Method for the prevention and/or treatment of autoimmune disease or allogeneic transplant rejections |
FR2941239B1 (en) * | 2009-01-19 | 2013-11-15 | Biomerieux Sa | METHOD FOR DETERMINING THE SUSCEPTIBILITY TO CONTRACT NOSOCOMIAL INFECTION IN A PATIENT WITH AN INFLAMMATORY SYSTEMIC RESPONSE ASSOCIATED WITH OR NOT ASSOCIATED WITH INFECTION |
WO2010082004A1 (en) | 2009-01-19 | 2010-07-22 | Biomerieux | Methods for determining the likelihood of a patient contracting a nosocomial infection and for determining the prognosis of the course of a septic syndrome |
FR2941240B1 (en) * | 2009-01-19 | 2013-05-10 | Biomerieux Sa | METHOD FOR DETERMINING THE SENSITIVITY OF A PATIENT TO CONTRACT A NOSOCOMIAL INFECTION |
US20130052665A1 (en) * | 2011-08-25 | 2013-02-28 | Bruce Xuefeng Ling | Methods for diagnosis of systemic juvenile idiopathic arthritis |
US20160297875A1 (en) * | 2013-12-07 | 2016-10-13 | Case Western Reserve University | Compositions and methods of treating thrombosis |
TWI704349B (en) * | 2019-06-17 | 2020-09-11 | 高雄榮民總醫院 | Use of protein biomarker for diagnosing kawasaki disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0263072B1 (en) * | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Novel lymphokine related peptides |
WO2002088181A2 (en) * | 2001-04-30 | 2002-11-07 | Switch Biotech Ag | Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances |
-
2003
- 2003-02-17 AU AU2003212246A patent/AU2003212246A1/en not_active Abandoned
- 2003-02-17 WO PCT/EP2003/001576 patent/WO2003069349A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003069349A3 (en) | 2004-02-05 |
WO2003069349A2 (en) | 2003-08-21 |
AU2003212246A8 (en) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003219689A1 (en) | Method and system for risk-modulated diagnosis of disease | |
AU2003301347A1 (en) | Methods for monitoring treatment of disease | |
AU2003253014A1 (en) | Method for the diagnosis and differential diagnosis of neurological diseases | |
AU2003224414A1 (en) | Acoustic diagnosis of sinusitis | |
AU2003277289A1 (en) | Method for diagnosing and interpreting dental conditions | |
AU2003301564A1 (en) | Method for improved diagnosis of dysplasias | |
AU2003212245A1 (en) | Method of diagnosis of inflammatory diseases using calgranulin c | |
AU2003212246A1 (en) | Method for diagnosis of inflammatory diseases using mrp8/mrp14 | |
AU2003299592A1 (en) | Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 | |
AU2002309180A1 (en) | Composition and kit for the treatment of inflammatory bowel diseases | |
EP1536005A4 (en) | Method of assaying interaction between proteins | |
EP1708961A4 (en) | Treatment of inflammatory bowel diseases with anti-ip-10 antibodies | |
AU2003218208A1 (en) | Methods for diagnosis and prognosis of cancer | |
AU2003280824A1 (en) | Method of organ regeneration | |
AU2003254895A1 (en) | Method of judging inflammatory disease | |
AU2003294206A1 (en) | Methods for diagnosing htlv-i-mediated diseases | |
AU2003283732A1 (en) | Method of tomographic imaging | |
AU2003251650A1 (en) | Screening for agents suitable for treatment of leukocyte associated inflammatory diseases | |
AU2003273243A1 (en) | Method for treating inflammatory bowel disease | |
AU2003900639A0 (en) | Novel method of treating inflammatory diseases | |
AU2003211623A1 (en) | Method of measuring the activity of dna-binding protein | |
AU2003293517A1 (en) | Methods of determining embryo viability | |
AU2003220903A1 (en) | Method of judging risk of peiodontal disease | |
IL158010A0 (en) | Methods and kits for the detection of prion diseases | |
AU2003263728A1 (en) | Method for diagnosis of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |